Fresenius | FRE - Selling And Administration Expenses


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Fresenius

Fresenius reported EUR1.53B in Selling and Administration Expenses for its fiscal quarter ending in March of 2023.


Selling And Administration Expenses Change
Akzo Nobel AKZA:NA EUR 796M 33M
Alcon AG ALC:SW USD 785M 23M
AstraZeneca AZN:LN USD 3.2B 331M
BASF BAS:GR EUR 2.6B 210M
Bayer BAYN:GR EUR 4.05B 374M
DaVita Healthcare Partners DVA:US USD 331.61M 48.1M
Demant A/s WDH:DC DKK 5.35B 453M
E.ON EOAN:GR EUR 1.66B 5M
Essilor EI:FP EUR 1.09B 72M
Fresenius FRE:GR EUR 1.53B 294M
Fresenius Medical Care FME:GR EUR 782M 172.3M
Getinge GETIB:SS SEK 2.06B 49M
Givaudan GIVN:VX CHF 533M 3M
GlaxoSmithKline GSK:LN GBP 2.06B 370M
GN Store Nord GN:DC DKK 1.45B 124M
Hikma Pharmaceutical HIK:LN USD 253M 3M
Merck MRK:GR EUR 1.47B 103M
Novartis NOVN:VX USD 3.4B 298M
Philips PHIA:NA EUR 1.24B 238M
Roche Holding ROG:VX CHF 6.48B 834M
RWE RWE:GR EUR 660M 174M
Smith & Nephew PLC SN/:LN USD 1.31B 101M